Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycans

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Cellular Physiology

• Publication date

  1984-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.1041180306PMID 6699099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelets stimulate aortic smooth muscle cell migration in vitro. Involvement of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

  1982cited by this paper
• Migration of cultured vascular cells in response to plasma and platelet-derived factors.

  1982cited by this paper
• Purification and properties of human platelet heparitinase.

  1982cited by this paper
• Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.

  1982cited by this paper
• Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor.

  1981cited by this paper
• What controls smooth muscle phenotype?

  1981cited by this paper
• Glycosaminoglycans in Morphogenesis

  1981cited by this paper
• Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

  1981cited by this paper
• Effect of extracellular glycosaminoglycans on the synthesis of collagen and proteoglycans by granulation tissue cells. A study with freshly isolated experimental granulation tissue cells of rat.

  1981cited by this paper
• Migration into an in vitro experimental wound: a comparison of porcine aortic endothelial and smooth muscle cells and the effect of culture irradiation.

  1981cited by this paper
• Effect of short- or long-term treatment with exogenous glycosaminoglycans on growth and glycosaminoglycan synthesis of human fibroblasts (WI-38) in culture.

  1980cited by this paper
• Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: In Vivo Studies with Anticoagulant and Nonanticoagulant Heparin

  1980cited by this paper
• Mast cell heparin stimulates migration of capillary endothelial cells in vitro

  1980cited by this paper
• Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides.

  1980cited by this paper
• Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: II. In Vitro Studies

  1980cited by this paper
• A role of secreted glycosaminoglycans in cell-substratum adhesion.

  1980cited by this paper
• Complexing of fibronectin glycosaminoglycans and collagen.

  1980cited by this paper
• Inhibition of cell proliferation and protease activity by cartilage factors and heparin.

  1980cited by this paper
• Migration of human vascular endothelial and smooth muscle cells.

  1979cited by this paper
• Heparin: an old drug with a new paradigm.

  1979cited by this paper
• Metabolism of sulfated glycosaminoglycans in cultured endothelial cells and smooth muscle cells from bovine aorta.

  1978cited by this paper
• The platelet-derived growth factor.

  1978cited by this paper
• Suppression by heparin of smooth muscle cell proliferation in injured arteries

  1977cited by this paper
• Memoirs: The Early Development of the Marsupialia, with Special Reference to the Native Cat (Dasyurys Viverrinus)

  1910cited by this paper

• Extension of the SUGRES-1P Coarse-Grained Model of Polysaccharides to Heparin

  2023cites this paper
• Smooth Muscle Cells

  2021cites this paper
• Biochemomechanics of the thoracic aorta in health and disease

  2020cites this paper
• Vascular Cells Proteome Associated with Bradykinin and Leptin Inflammation and Oxidative Stress Signals

  2020cites this paper
• Polycaprolactone vascular graft with epigallocatechin gallate embedded sandwiched layer-by-layer functionalization for enhanced antithrombogenicity and anti-inflammation.

  2020cites this paper
• Persulfated flavonoids accelerated re-endothelialization and improved blood compatibility for vascular medical implants.

  2019cites this paper
• A heparin-functionalized woven stent graft for endovascular exclusion.

  2019cites this paper
• Coaxial electrospinning of P(LLA-CL)/heparin biodegradable polymer nanofibers: potential vascular graft for substitution of femoral artery.

  2019cites this paper
• Macroporous nanofibrous vascular scaffold with improved biodegradability and smooth muscle cells infiltration prepared by dual phase separation technique

  2018cites this paper
• Layered double hydroxide nanoparticles: Impact on vascular cells, blood cells and the complement system.

  2018cites this paper
• Mechanocompatible Polymer‐Extracellular‐Matrix Composites for Vascular Tissue Engineering

  2016cites this paper
• Heparin Inhibits Proliferation and Migration of Patient-Derived Vascular Cells Only at Non-physiological Concentrations Due to Antagonistic Pathways

  2016cites this paper
• Invasion and Anti-Invasion Research of Glioma Cells in An Improved Model of Organotypic Brain Slice Culture

  2015cites this paper
• Engineering poly (ethylene glycol) hydrogels to regulate smooth muscle cell migration and proliferation

  2014cites this paper
• Intimal Hyperplasia. Experimental and Clinical Studies

  2014cites this paper
• Effects of enoxaparin and dalteparin on proliferation and migration of patient-derived vascular smooth muscle cells.

  2014cites this paper
• Decorin Mimic Inhibits Vascular Smooth Muscle Proliferation and Migration

  2013cites this paper
• mimic inhibits vascular smooth muscle proliferation and migration.

  2013cites this paper
• Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.

  2012cites this paper
• Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1.

  2012cites this paper
• Design and development of multilayer vascular graft

  2011cites this paper
• SDF‐1α/CXCR4 axis is involved in glucose‐potentiated proliferation and chemotaxis in rat vascular smooth muscle cells

  2010cites this paper
• Anti-proliferative compounds for the prevention of restenosis.

  2010cites this paper
• Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells

  2010cites this paper
• Enhanced effects of low molecular weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle cells.

  2010cites this paper
• THROMBOELASTOGRAPHY IN THE ASSESSMENT OF COAGULATION CHANGES IN PERIPHERAL VASCULAR DISEASE

  2010cites this paper
• 17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression.

  2010cites this paper
• PGC-1α Is a Key Regulator of Glucose-Induced Proliferation and Migration in Vascular Smooth Muscle Cells

  2009cites this paper
• Gastrointestinal absorption of heparins

  2009cites this paper
• Non‐enzymatic glycation of type I collagen diminishes collagen–proteoglycan binding and weakens cell adhesion

  2008cites this paper
• Wirkungen der Gerinnungsfaktoren Thrombin und Faktor-Xa auf vaskuläre Zellen des Menschen

  2008cites this paper
• Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.

  2008cites this paper
• Hyperplasie intimale artérielle par prolifération de cellules musculaires lisses dans la paroi

  2008cites this paper
• Increased Static Pressure Promotes Migration of Vascular Smooth Muscle Cells: Involvement of the Rho-kinase Pathway

  2008cites this paper
• Endothelial Regeneration

  2007cites this paper
• Cinematographic analysis of vascular smooth muscle cell interactions with extracellular matrix

  2007cites this paper
• The role of microglia in glioma invasiveness

  2007cites this paper
• Vascular Remodeling in Health and Disease

  2007cites this paper
• PGC-1α Inhibits Oleic Acid Induced Proliferation and Migration of Rat Vascular Smooth Muscle Cells

  2007cites this paper
• Endothelial cell migration on surface-density gradients of fibronectin, VEGF, or both proteins.

  2007cites this paper
• CALL FOR PAPERS Regulation of Cardiovascular Functions by Eicosanoids and Other Lipid Mediators Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells

  2006cites this paper
• Patterning cellular motility using an electrochemical technique and a geometrically confined environment.

  2006cites this paper
• Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.

  2006cites this paper
• Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells.

  2006cites this paper
• Spatiotemporal control of cell adhesion on a self-assembled monolayer having a photocleavable protecting group.

  2006cites this paper
• Heparin Decreases Activator Protein-1 Binding

  2005cites this paper
• Arterial Smooth Muscle Cells

  2005cites this paper
• Smooth Muscle Cell Proliferation After Intramural Heparin Delivery

  2005cites this paper
• Rad GTPase Attenuates Vascular Lesion Formation by Inhibition of Vascular Smooth Muscle Cell Migration

  2005cites this paper
• Regulation of Cardiovascular Functions by Eicosanoids and Other Lipid Mediators Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells

  2005cites this paper
• Development of the Pulmonary Vasculature

  2004cites this paper
• Measurement of cell migration on surface-bound fibronectin gradients.

  2004cites this paper
• Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells

  2004cites this paper
• Efficient inhibition of in-stent restenosis by controlled stent-based inhibition of elastase: a pilot study.

  2004cites this paper
• Mechanisms of angiotensin II-induced expression of B2 kinin receptors.

  2004cites this paper
• Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells.

  2004cites this paper
• Thrombin- and Factor Xa–Induced DNA Synthesis Is Mediated by Transactivation of Fibroblast Growth Factor Receptor-1 in Human Vascular Smooth Muscle Cells

  2004cites this paper
• [Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives].

  2003cites this paper
• CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility.

  2003cites this paper
• Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.

  2003cites this paper
• Heparin inhibits the motility and proliferation of human myometrial and leiomyoma smooth muscle cells.

  2003cites this paper
• Interactions of heparin with human skin cells: binding, location, and transdermal penetration.

  2003cites this paper
• Glycosaminoglycan-degrading enzymes in the skin of fasted rats.

  2002cites this paper
• In Vivo Vascular Engineering: Directed Migration of Smooth Muscle Cells to Limit Neointima

  2002cites this paper
• The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans.

  2002cites this paper
• The Angiogenic Factor Cysteine-Rich 61 (CYR61, CCN1) Supports Vascular Smooth Muscle Cell Adhesion and Stimulates Chemotaxis through Integrin α6β1 and Cell Surface Heparan Sulfate Proteoglycans.

  2002cites this paper
• Inhibition of rat smooth muscle cell adhesion and proliferation by non‐anticoagulant heparins

  2002cites this paper
• The Antimitogenic Action of the Sulphated Polysaccharide Fucoidan Differs from Heparin in Human Vascular Smooth Muscle Cells

  2002cites this paper
• Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model

  2002cites this paper
• Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells.

  2002cites this paper
• Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor‐2 biological activity through different fibroblast growth factor receptors

  2001cites this paper
• Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia.

  2001cites this paper
• Versican V1 Proteolysis in Human Aorta in Vivo Occurs at the Glu441-Ala442 Bond, a Site That Is Cleaved by Recombinant ADAMTS-1 and ADAMTS-4*

  2001cites this paper
• Therapeutic elastase inhibition by alpha-1-antitrypsin gene transfer limits neointima formation in normal rabbits.

  2001cites this paper
• Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells.

  2001cites this paper
• Regulation of B2-kinin receptors by glucose in vascular smooth muscle cells

  2001cites this paper
• Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells.

  2001cites this paper
• Evaluation of endothelial cell migration with a novel in vitro assay system.

  2000cites this paper
• Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.

  2000cites this paper
• Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.

  2000cites this paper
• Polysaccharides for vascular cell targeting.

  2000cites this paper
• Interaction of native and modified low-density lipoproteins with extracellular matrix

  2000cites this paper
• Local delivery of nadroparin via hydrogel-coated angioplasty balloon: effect on platelet deposition and smooth muscle cell proliferation--an experimental study.

  2000cites this paper
• Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK.

  2000cites this paper
• Percutaneous Periadventitial Heparin Delivery via Crosslinked Liquid Polymer

  2000cites this paper
• Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-β and MAPK

  2000cites this paper
• Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells.

  2000cites this paper
• Development of the Pulmonary Vasculature

  1999cites this paper
• Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c-fos induction in vascular cells

  1999cites this paper
• Studies on wound healing: effects of calcium D-pantothenate on the migration, proliferation and protein synthesis of human dermal fibroblasts in culture.

  1999cites this paper
• Characterization of [3H]‐heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis

  1999cites this paper
• Glycoprotein Ibalpha can mediate endothelial cell migration on von Willebrand factor-containing substrata.

  1999cites this paper
• Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1

  1999cites this paper
• Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells.

  1999cites this paper
• Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology.

  1999cites this paper
• Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c- fos induction in vascular cells.

  1999cites this paper
• Inhibitory mechanisms by which suramin may attenuate neointimal formation after balloon angioplasty.

  1999cites this paper
• Airway smooth muscle cell proliferation: characterization of subpopulations by sensitivity to heparin inhibition.

  1998cites this paper
• Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.

  1998cites this paper
• Airway smooth muscle cell proliferation: characterization of subpopulations by sensitivity to heparin inhibition.

  1998cites this paper